Health Canada issues notice on medical device e-labelling
This article was originally published in SRA
Health Canada issued on 9 November a notice on electronic labelling requirements for certain medical devices that takes effect immediately1.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
GenSight Biologics believes Lumevoq could become the first curative treatment for Leber hereditary optic neuropathy.